Health Trials

Studies on Adsorption International Learning Initiative Global

ConditionsCKD (Chronic Kidney Disease) Stage 5DUremia; ChronicUremic; ToxemiaInflammation ChronicHemodialysisInflammation BiomarkersDialysis Related ComplicationAnemia Associated With End Stage Renal Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBotkin Hospital

About this trial

Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia

Eligibility criteria

Qualifiers

Adequate dialysis defined by a KT/V index ≥ 1.4

No active inflammatory process or infection

Age ≥ 18 years

Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session

Disqualifiers

Current use of steroids or immunosuppressive therapy

History of kidney transplantation

Diagnosis of cancer

Pregnancy

Trial design

Treatments tested in this trial

  • Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafron HA130 contains the original adsorbing material.

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Botkin Hospital

Lead sponsor

Source ClinicalTrials.gov